Senior insider sale
Chief Medical Officer at AKTIS ONCOLOGY, INC. — senior position signals high conviction
$1.94M
75K shares
What this filing means
CZIBERE AKOS plans to sell 75K shares of AKTIS ONCOLOGY, INC. valued at approximately $1.94M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 9/23/2026ACC: 0001950047-26-009770
Officer· Chief Medical Officer
Since Jan 2026
75K
Shares to sell
$1.94M
Approx. market value
25K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
Cash
9/23/2026
25KTotal acquired25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/23/2026 | Exercise of Stock Options Cash | 25K | — |
| Total | 25K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
50K
Market value
$1.39M
7/8/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
25K
Market value
$552.8K
9/23/2026
Total
Units
75K
Value
$1.94M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
7/8/2026 | 50K | $1.39M | — | Completed |
| Planned — Approximate Date | ||||
9/23/2026 | 25K | $552.8K | NASDAQ | Planned |
| Total | 75K | $1.94M | ||